-
UPC Roundup (1 week): second medical use; evidence gathering through on-site experiments; various new cases
Read more: UPC Roundup (1 week): second medical use; evidence gathering through on-site experiments; various new casesThis is a summary of developments in and around the Unified Patent Court (UPC) in the week since our May 10, 2025 UPC Roundup. Only a few noteworthy things happened. 1. CoA: confidentiality concerns don’t warrant splitting up case In Corning v. Hisense, TCL and LG, Standing Judge (of the Court of Appeal (CoA)) Patricia Rombach affirmed…
-
Illumina sues Element Biosciences in Delaware over gene sequencing patents
Read more: Illumina sues Element Biosciences in Delaware over gene sequencing patentsWhile this is Illumina’s first official suit against Element Biosciences, the latter has already faced challenges over its gene sequencing technology based on prior art from Illumina’s assets.
-
Two U.S. pharma patent disputes fail to make it to trial: Alnylam concedes first round of litigation against Pfizer, BioNTech in COVID vaccine war, Nexus obtains summary judgment of invalidity
Read more: Two U.S. pharma patent disputes fail to make it to trial: Alnylam concedes first round of litigation against Pfizer, BioNTech in COVID vaccine war, Nexus obtains summary judgment of invalidityWhile Alnylam has dropped its patent infringement dispute against Pfizer, BioNTech, and Ingenus Pharmaceuticals has failed to take its cancer dispute to trial, both cases are subject to appeal.
-
10x Genomics and Bruker (NanoString) end global patent dispute
Read more: 10x Genomics and Bruker (NanoString) end global patent disputeThe UPC’s first major patent dispute has ended after the companies signed a global cross-license patent agreement.
-
New study: Huawei leads WiFi 7 SEP ownership, Ericsson sole European patentee
Read more: New study: Huawei leads WiFi 7 SEP ownership, Ericsson sole European patenteeA report on WiFi 7 SEP ownership published by GreyB today has found European patentees lag way behind those in Mainland China and the U.S., with Ericsson being the only patentee mentioned from the region.
-
UPC Dusseldorf issues first decision on second medical use, hands win to Amgen in cholesterol patent dispute against Sanofi
Read more: UPC Dusseldorf issues first decision on second medical use, hands win to Amgen in cholesterol patent dispute against SanofiThe Dusseldorf Local Division has clarified how the UPC deals with second medical use in patent infringement proceedings, including considering the extent or significance of the allegedly infringing use, and whether an entity is “positively” or “negatively” influencing a market by encouraging infringement, or preventing a product from being used for patented use.
-
Speakers now live: IP Dealmakers Europe + LF Dealmakers Europe (London, June 23-25)
Read more: Speakers now live: IP Dealmakers Europe + LF Dealmakers Europe (London, June 23-25)The events, for which ip fray is an official media partner, will feature keynotes from Hodge Malek KC, chairman of the UK’s Competition Appeal Tribunal, and Tudor Brown, co-founder of British semiconductor firm ARM.
-
Nintendo’s Japanese patent lawsuit against Pocketpair produces only losers, annoys consumers: game rules are wrong subject matter
Read more: Nintendo’s Japanese patent lawsuit against Pocketpair produces only losers, annoys consumers: game rules are wrong subject matterContext: In January 2024, a small Japanese game maker named Pocketpair released Palworld, a game that literally became an overnight success of enormous proportions. It was described by some as “Pokémon with guns,” and Pokémon is Nintendo’s (and a joint venture name The Pokémon Company’s) crown jewel, besides Super Mario. That same month, the IP…
Follow Us
Latest Articles
- SEP holders can deprive Tesla’s pursuit of judicial FRAND rate-setting for patent pools of any basis if they want
- China is “back” in SEP enforcement: CNIPA’s 2026 Working Scheme channels SEP disputes into administrative proceedings
- Google petitions U.S. Supreme Court over Patent Trial & Appeal Board “settled expectations” denials
- Tesla tells UKSC it shouldn’t have to do what much smaller companies like Doro, Emporia, Nothing can do — and relies on SME astroturfers
- Google’s PTAB barrage against K.Mizra draws hold-out accusation in latest filing